Drug profile

The FDA adverse-event record for Amoxicillin & Clavulanic Acid

99 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Amoxicillin & Clavulanic Acid. See the species affected, top reactions, and outcomes below.

99
adverse-event reports
22.2%
death-coded share
Dog
most-reported species
17
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
99
Total Reports
22
Deaths Reported
22.2%
Death Rate

Active Ingredients

Amoxicillin & Clavulanic Acid

Administration Routes

OralUnknown

Species Affected

Dog 89
Cat 10

Most Affected Breeds

Retriever - Golden 11
Retriever - Labrador 10
Domestic Shorthair 5
Chihuahua 4
Terrier - Bull - American Pit 4
Boxer (German Boxer) 4
Shih Tzu 3
Bulldog - French 3
Dog (unknown) 3
Catahoula Leopard Dog 3

Most Reported Reactions

Vomiting 17
Other abnormal test result NOS 15
Death by euthanasia 14
Lethargy (see also Central nervous system depression in 'Neurological') 14
Diarrhoea 11
Lack of efficacy - NOS 10
Elevated serum alkaline phosphatase (SAP) 10
Seizure NOS 9
Death 8
Leucocytosis NOS 8
Decreased appetite 8
Thrombocytopenia 7

Outcome Breakdown

Ongoing
53 (53.0%)
Recovered/Normal
18 (18.0%)
Euthanized
14 (14.0%)
Died
8 (8.0%)
Outcome Unknown
7 (7.0%)

Amoxicillin & Clavulanic Acid Adverse Event Insights

99 reports name Amoxicillin & Clavulanic Acid; 22 recorded a death outcome (22.2% of reported events, not a population-level mortality rate). Active ingredient: Amoxicillin & Clavulanic Acid. Administration routes: Oral, Unknown.

By species: Dog (89 reports), Cat (10 reports). By breed: Retriever - Golden (11), Retriever - Labrador (10), Domestic Shorthair (5).

Leading clinical signs: Vomiting (17), Other abnormal test result NOS (15), Death by euthanasia (14), Lethargy (see also Central nervous system depression in 'Neurological') (14). Outcome, 100 coded reports: Ongoing leads at 53.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.